BrightSpring Health Services, Inc. Common Stock (BTSG) Stock Analysis
Market Closed
Sector: Healthcare · Industry: Services-Home Health Care Services
What's happening with BTSG
Price History
5-Year Weekly Candlestick Chart
Profile
Strong earnings quality; growth and profitability lag behind.
How is each axis scored?
- Valuation67/100 · Moderate
- P/E vs own history (12th pct)25/25
- FCF yield (3.8%)12/25
- P/S (0.8x)25/25
- EV/EBIT (34.1x)5/25
- Growth32/100 · Weak
- Revenue CAGR (14.6%)20/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (5.4%)12/25
- Profitability43/100 · Weak
- ROIC (8.2%)12/25
- ROE (15.7%)20/25
- Net margin (2.3%)6/25
- Operating margin (2.7%)5/25
- Financial Health58/100 · Moderate
- Altman Z (2.61)18/25
- Current ratio (1.74)18/25
- Interest coverage (3.1x)10/25
- Net cash / debt (D/A 25%)12/25
- Quality84/100 · Strong
- Piotroski F (7/9)22/25
- Beneish M (-2.16)12/25
- FCF conversion (133%)25/25
- Margin stability (σ 0.6%)25/25
About BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Show more
Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Headquarters: LOUISVILLE, KY · Employees: 23,500 · Website ↗
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 21, 2026
Insider Transactions
Recent SEC Form 4 filings
- SellTax withholding · filed 2026-07-28-56319 sh2026-07-25
- SellTax withholding · filed 2026-06-22-2487 sh2026-06-20
- BuyGrant / award · filed 2026-06-12+4.0K sh2026-06-11
- SellOption exercise · filed 2026-06-05-35000 sh2026-06-05
- SellOpen market sale · filed 2026-06-05-35000 sh2026-06-05
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
67BP/E (TTM)39.4xD
Grade D: Exp.Price / TTM EPS (own statements) — vs own 3Y history: 30.0x–76.0x · 12th pct
P/FCF27.5xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield3.8%C
Grade C: LowTTM FCF / Market Cap — vs own 3Y history: -8.4%–4.5% · 92nd pct
P/S (TTM)0.80xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 3Y history: 0.2x–1.2x · 85th pct
EV/EBIT34.1xD
Grade D: Exp.Enterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 3Y history: 27.1x–50.2x · 24th pct
EV/Sales0.9xA
Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E37.4xD
Grade D: Exp.Price / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio5.52xC
Grade C: Exp.Price to Book Value. Neg. equity = heavy buybacks
PEG Ratio2.39C
Grade C: Exp.Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
43D+ROIC8.2%C
Grade C: AvgNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE15.7%C
Grade C: AvgReturn on Equity. Neg. equity = heavy buybacks
ROA5.9%C
Grade C: AvgReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin2.3%D
Grade D: LowNet Income / Revenue
Operating Margin2.7%D
Grade D: LowTTM EBIT / TTM Revenue
Gross Margin12.2%D
Grade D: LowGross Profit / Revenue
FCF Margin3.0%D
Grade D: LowFCF / Revenue
True FCF Margin2.6%D
Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
58CAltman Z-Score2.61C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.74xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.10xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage3.1xC
Grade C: OkEBIT/Interest. >10 Strong
Debt Repayment3.8yC
Grade C: AvgYears to repay net debt via FCF
Net Debt/EBIT4.3xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity1.24xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.36xC
Grade C: PartialCash covers how much of total debt. >1 = could repay all debt from cash
Growth
32DRevenue CAGR14.6%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Forward Growth5.4%B
Grade B: LowImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income18.7%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.4%A
Grade A: LowTTM stock-based comp / TTM Revenue
Quality
1/2 Loss Years84APiotroski F-Score7/9A
Grade A: StrongFinancial strength 0–9. >7 Strong
Beneish M-Score-2.16C
Grade C: Gray zoneEarnings manipulation risk. < -2.22 Safe
FCF Conversion133.0%A
Grade A: StrongFCF / Net Income
Margin Stability0.6%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue0.7%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover2.01xA
Grade A: HighRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Per Share
EPS (TTM)$1.40
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$0.46
Cash & short-term investments per share (Finnhub)
Book Value / Share$9.76
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$2.44B
Total debt obligations (short + long term)
Cash & Equiv.$888.80M
Cash and short-term investments
Net Debt$1.56B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$1.98B
Shareholders' equity (book value)
Asset / Liability1.47xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$10.92B
Current Market Capitalization
Beta1.89D
Grade D: H.VolPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
BTSG predstavuje priemerne atraktívnu investíciu, pri ktorej rozumné ocenenie a rýchla splatnosť dlhu narážajú na slabšiu profitabilitu a hraničnú finančnú stabilitu v šedej zóne.
Takes ~3.8 years to repay net debt from free cash flow. · Current P/E of 39.4x sits at the 12th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 22, 2026
Key Insights: BrightSpring Health Services, Inc. Common Stock (BTSG)
Composite verdict for BrightSpring Health Services, Inc. Common Stock: BTSG predstavuje priemerne atraktívnu investíciu, pri ktorej rozumné ocenenie a rýchla splatnosť dlhu narážajú na slabšiu profitabilitu a hraničnú finančnú stabilitu v šedej zóne.. BrightSpring Health Services, Inc. Common Stock meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 2.61 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out.
- Takes ~3.8 years to repay net debt from free cash flow.
- BrightSpring Health Services, Inc. Common Stock posted a net loss in 1 of 2 available completed fiscal years (2024–2025).
See how BTSG ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for BTSG in the last 30 days.
See BTSG move history →Frequently Asked Questions about BTSG
Is BTSG stock a buy right now?
PreMarketPrice's quantitative model rates BrightSpring Health Services, Inc. Common Stock's financial health at 58/100 — BTSG predstavuje priemerne atraktívnu investíciu, pri ktorej rozumné ocenenie a rýchla splatnosť dlhu narážajú na slabšiu profitabilitu a hraničnú finančnú stabilitu v šedej zóne.. This is a data-driven snapshot of fundamentals, not investment advice.
Is BTSG stock overvalued?
BrightSpring Health Services, Inc. Common Stock trades at a trailing P/E of 39.4 and our valuation score rates it 67/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does BrightSpring Health Services, Inc. Common Stock report earnings?
No confirmed earnings date is currently scheduled for BTSG. The Earnings section lists recent reports and updates as dates are announced.
What sector does BrightSpring Health Services, Inc. Common Stock operate in?
BrightSpring Health Services, Inc. Common Stock operates in the Healthcare sector, within the Services-Home Health Care Services industry. The Related Stocks section lists sector peers for comparison.
What does BrightSpring Health Services, Inc. Common Stock do?
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients.
About BrightSpring Health Services, Inc. Common Stock (BTSG) Stock
BrightSpring Health Services, Inc. Common Stock (BTSG) is a US-listed stock operating in the Healthcare sector, specifically the Services-Home Health Care Services industry. Real-time pricing data for BrightSpring Health Services, Inc. Common Stock is available on this page with a market capitalization of $10.9 billion. The financial health score for BTSG is 58/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for BTSG stock.
BTSG Stock Analysis & Key Metrics
On PreMarketPrice, you can track BrightSpring Health Services, Inc. Common Stock (BTSG) across multiple dimensions:
- Pre-market price & movement: Real-time BTSG stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for BTSG with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for BrightSpring Health Services, Inc. Common Stock across multiple reporting periods.
- Financial health score: A composite score of 58/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for BTSG.
- Sector peers: Compare BTSG against 10 other healthcare stocks on key financial metrics.
Is BTSG a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate BrightSpring Health Services, Inc. Common Stock (BTSG) as an investment. The financial health score of 58/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.BrightSpring Health Services, Inc. Common Stock (BTSG) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.